London, UK, 2 April 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has appointed Professor Tony Cass to its Scientific Advisory Board.
Professor Cass is Professor of Chemical Biology, Deputy Director and Bio-nanotechnology Research Director in the Institute of Biomedical Engineering at Imperial College London. He is also a Founder and Executive Director of the BioNano Centre, an R&D and technology transfer centre owned jointly by University College London and Imperial College London.
Professor Cass’ research interests are in the field of analytical biotechnology and particularly in the use of protein engineering and design to produce new reagents for biosensors and bioanalysis. He pioneered the use of synthetic electron transfer mediators for enzyme biosensors leading to the development of the first electronic blood glucose measuring system (commercialised by Abbott Diagnostics) and the award of the Royal Society’s Mullard Medal.
Professor Cass holds a PhD in Chemistry from the University of Oxford and is a Fellow of the Royal Society of Chemistry.
“We are delighted to welcome Tony Cass to our SAB and look forward to the benefit of his longstanding experience in developing and commercialising nanotechnologies” said Dr Yen Choo, Plasticell’s Chief Executive.
Plasticell is a privately held, London-based biotechnology company using innovative, high throughput stem cell technologies and novel drug discovery platforms to dissect the mechanisms leading to differentiation of stem cells, the master cells responsible for tissue development and repair. Plasticell’s research focus is to discover regenerative small molecule drugs. The company also forms industry alliances by partnering its Combinatorial Cell Culture™ technology for high throughput stem cell differentiation to derive cell lines and reagents for research and therapy applications. For more information please visit the company’s website: www.plasticell.co.uk